Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 12 Cognitive Dysfunction 4 Radiation Injuries 3 Neoplasms 3 Multiple Myeloma 3 Glioma 3 Lymphoma, B-Cell 2 Lymphoma 2 Glioblastoma 2 Fatigue 2 Breast Neoplasms 2 Astrocytoma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Sarcoma 1 Pituitary Neoplasms 1 Parkinson Disease 1 Osteosarcoma 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neurofibromatosis 1 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

AZD 6244 9 Lovastatin 5 Deoxycholic Acid 4 trametinib 3 Lasers, Solid-State 3 mirdametinib 2 fludarabine 2 Transcranial Direct Current Stimulation 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Acetylcysteine 2 thymoglobulin 1 talimogene laherparepvec 1 peginterferon alfa-2b 1 gadolinium compound P760 1 fludarabine phosphate 1 diphenylcyclopropenone 1 cabozantinib 1 binimetinib 1 X-Rays 1 Vitamin D 1 Vincristine 1 Vinblastine 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neurofibromatosis 1 × Neuropsychological Tests × Clear all

NCT01851135 2016-07-06

NF1-QDV

Nantes University Hospital

Phase NA Completed

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡